Tag: BRCA; breast cancer; ovarian cancer; hereditary cancer; genetic testing; breast cancer risk; ovarian cancer risk; HBOC; genetic counseling; pedigree; family history; risk assessment; prophylactic ooph

Guest post by Sue Friedman On April 15, 2013, the U.S. Supreme Court heard arguments on whether Myriad Genetics’ patents on the BRCA genes, which are associated with hereditary breast and ovarian cancer, should be upheld. This case culminates a four-year legal tug-of-war between Myriad Genetics & Laboratories and a long list of individual, advocacy,…

Guest post by Sue Friedman On April 15, 2013, the U.S. Supreme Court heard arguments on whether Myriad Genetics’ patents on the BRCA genes, which are associated with hereditary breast and ovarian cancer, should be upheld. This case culminates a four-year legal tug-of-war between Myriad Genetics & Laboratories and a long list of individual, advocacy,…